论文部分内容阅读
目的:探讨纤维支气管镜治疗急危重症合并严重肺部感染的疗效。方法:选择2012年1月至2014年6月之间收治的100例急危重症合并严重肺部感染患者为观察对象,随机将其分为对照组和实验组,每组各50例,对照组接受基础抗感染治疗,实验组接受纤维支气管镜治疗,对比分析两组患者临床疗效。结果:实验组患者临床治疗的总有效率明显高于对照组(P<0.05)。结论:纤维支气管镜是一种较为有效的急危重症合并严重肺部感染患者临床治疗方法,有助于患者病灶的缩小以及临床症状改善。
Objective: To investigate the curative effect of bronchofibroscopy in the treatment of acute and severe cases with severe pulmonary infection. Methods: A total of 100 acute critically ill patients with severe pulmonary infection who were treated between January 2012 and June 2014 were selected as observation subjects and randomly divided into control group and experimental group, with 50 cases in each group and control group The patients received basic anti-infective therapy. The experimental group received bronchofiberscopy and compared the clinical efficacy of the two groups. Results: The total effective rate of clinical treatment in experimental group was significantly higher than that in control group (P <0.05). Conclusion: Fiberoptic bronchoscopy is a more effective method for clinical treatment of patients with severe and severe acute respiratory infection, which can help reduce the size of patients and improve the clinical symptoms.